A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics
出版年份 2022 全文链接
标题
A Shared Nephroprotective Mechanism for Renin-Angiotensin-System Inhibitors, Sodium-Glucose Co-Transporter 2 Inhibitors, and Vasopressin Receptor Antagonists: Immunology Meets Hemodynamics
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 7, Pages 3915
出版商
MDPI AG
发表日期
2022-04-02
DOI
10.3390/ijms23073915
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD
- (2021) Eric Yuk Fai Wan et al. Clinical Journal of the American Society of Nephrology
- Renin-angiotensin system and inflammation update
- (2021) Elena Cantero-Navarro et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial
- (2021) Peter Rossing et al. DIABETES OBESITY & METABOLISM
- Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
- (2021) Rajiv Agarwal et al. EUROPEAN HEART JOURNAL
- Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
- (2021) Rajiv Agarwal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy
- (2020) Didier Collard et al. HYPERTENSION
- Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial
- (2020) Meg J. Jardine et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Association of glomerular hyperfiltration with serum chemokine levels and metabolic features in prepubertal children with overweight/obesity
- (2020) María L. Muzzio et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease
- (2020) So Ra Kim et al. Nature Communications
- Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
- (2020) Andrew Gibson et al. CHEMICAL RESEARCH IN TOXICOLOGY
- The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial
- (2020) Hitoshi Minakuchi et al. Scientific Reports
- Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review
- (2020) Li Zhang et al. World Journal of Diabetes
- Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis
- (2019) Ricky D. Turgeon et al. PLoS One
- Renal response to an oral protein load in patients with central diabetes insipidus before and after treatment with vasopressin
- (2019) Davide Viggiano et al. JOURNAL OF NEPHROLOGY
- Effect of tocilizumab, an interleukin-6 inhibitor, on early stage streptozotocin-induced diabetic nephropathy in rats
- (2019) Aly M. Abdelrahman et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function
- (2019) Hiroki Kobayashi et al. HYPERTENSION
- Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes
- (2019) Yutian Lei et al. Frontiers in Immunology
- Does the temporary decrease in the estimated glomerular filtration rate (eGFR) after initiation of mineralocorticoid receptor (MR) antagonist treatment lead to a long-term renal protective effect?
- (2019) Atsuhisa Sato HYPERTENSION RESEARCH
- Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages
- (2019) Yi-Hsuan Lin et al. Frontiers in Endocrinology
- Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
- (2019) Hiddo J L Heerspink et al. Lancet Diabetes & Endocrinology
- Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
- (2018) Marie E. Edwards et al. Clinical Journal of the American Society of Nephrology
- Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
- (2018) Davide Viggiano et al. KIDNEY & BLOOD PRESSURE RESEARCH
- A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan
- (2018) Fouad T. Chebib et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Can We DECLARE a Victory against Cardio-Renal Disease in Diabetes?
- (2018) Kim A. Connelly et al. Cell Metabolism
- Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts
- (2017) Tsung-Ming Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
- (2017) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Effect of Calcium Channel Blockers on Glomerular Function in Hypertensive Patients with Diabetes Mellitus
- (2017) Yayoi Nishida et al. Drugs in research & development
- Glomerular filtration rate in patients with psoriasis treated with etanercept
- (2016) Paolo Gisondi et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduction of Tubular Flow Rate as a Mechanism of Oliguria in the Early Phase of Endotoxemia Revealed by Intravital Imaging
- (2015) D. Nakano et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial
- (2015) Ron T. Gansevoort et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 Study
- (2014) Lawrence A. Leiter et al. DIABETES CARE
- Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials
- (2014) M. V. Irazabal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease
- (2014) Hyun Woo Kim et al. RHEUMATOLOGY INTERNATIONAL
- Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease
- (2013) Olivier Devuyst et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease
- (2013) Wendy E. Boertien et al. KIDNEY INTERNATIONAL
- PED/PEA-15 induces autophagy and mediates TGF-beta1 effect on muscle cell differentiation
- (2012) S Iovino et al. CELL DEATH AND DIFFERENTIATION
- Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease
- (2012) A. B. Chapman et al. Clinical Journal of the American Society of Nephrology
- Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
- (2012) P. Ruggenenti et al. DIABETES CARE
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adalimumab treatment in patients with rheumatoid arthritis with renal insufficiency
- (2012) Keiichi Sumida et al. ARTHRITIS CARE & RESEARCH
- Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Three Years' Experience
- (2011) E. Higashihara et al. Clinical Journal of the American Society of Nephrology
- Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy
- (2011) Kathrin Eller et al. DIABETES
- An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
- (2011) Frank A. Holtkamp et al. KIDNEY INTERNATIONAL
- The intact nephron hypothesis: the concept and its implications for phosphate management in CKD-related mineral and bone disorder
- (2011) Eduardo Slatopolsky KIDNEY INTERNATIONAL
- Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease
- (2011) Maria V. Irazabal et al. KIDNEY INTERNATIONAL
- The HALT Polycystic Kidney Disease Trials: Design and Implementation
- (2010) A. B. Chapman et al. Clinical Journal of the American Society of Nephrology
- Rate of Kidney Function Decline Associates with Mortality
- (2010) Z. Al-Aly et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serum cystatin C level in patients with rheumatoid arthritis after single infusion of infliximab
- (2010) M. Kopec-Medrek et al. RHEUMATOLOGY INTERNATIONAL
- The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease
- (2009) A. K. Ahmed et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search